SCHEMBL6274675

SCHEMBL6274675

CC1CCC(C)C(C(=O)NCC(N)=O)C1.CC1CCC(C)C(C(=O)O)C1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.40
TRPM8 Q7Z2W7 1/20 0.35
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6272935 0.94 EPHX1 (0.44) EPHX1TRPM8POLB
SCHEMBL6762833 0.94 EPHX1 (0.44) EPHX1TRPM8POLB
SCHEMBL6710245 0.94 EPHX1 (0.44) EPHX1TRPM8POLB
SCHEMBL6268429 0.83 EPHX1 (0.41) EPHX1TRPM8POLB
SCHEMBL3336695 0.79 EPHX1 (0.42) EPHX1TRPM8
SCHEMBL6274682 0.79 EPHX1 (0.42) EPHX1TRPM8
SCHEMBL6268386 0.77 EPHX1 (0.53) EPHX1
SCHEMBL6275638 0.74 EPHX1 (0.55) EPHX1
SCHEMBL6274792 0.73 AAK1 (0.40) EPHX1
SCHEMBL6271399 0.72 PLG (0.39) EPHX1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606244-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT Abbott Laboratories (US) 2005-12-21 EP disclosed
WO-2004037769-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT ABBOTT LABORATORIES (US) 2004-05-06 WO disclosed